Abstract
Staphylococcus aureus is the leading cause of surgical site infections (SSI) in the United States. In particular, SSI caused by methicillin-resistant Staphylococcus aureus (MRSA) has emerged as a devastating complication, leading to increased mortality rates, increased length of hospitalization, and increased costs. Proven strategies for prevention of SSI caused by S aureus include addressing modifiable risk factors and correct choice and timing of antimicrobial prophylaxis. Other strategies, including decolonization and the use of vancomycin, remain controversial.
Original language | English (US) |
---|---|
Pages (from-to) | 53-72 |
Number of pages | 20 |
Journal | Infectious Disease Clinics of North America |
Volume | 23 |
Issue number | 1 |
DOIs | |
State | Published - Mar 2009 |
Externally published | Yes |
All Science Journal Classification (ASJC) codes
- Microbiology (medical)
- Infectious Diseases
Keywords
- Antimicrobial prophylaxis
- Epidemiology
- Surgical site infection